Array
(
    [id] => 2174
    [catid] => 311
    [title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
    [thumb] => 
    [keywords] => 
    [description] => 
    [hits] => 
    [uid] => 3
    [author] => 甘肃中医院
    [status] => 9
    [url] => https://www.anes-guide.com/show/2174.html
    [link_id] => 0
    [tableid] => 0
    [inputip] => 14.105.95.116
    [inputtime] => 2024-12-19 09:42:42
    [updatetime] => 2024-12-19 09:42:42
    [displayorder] => 0
    [nrjc] => Array
        (
        )
    [nrsh] => Array
        (
        )
    [xzl] => 0
    [dzl] => 0
    [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
    [demo_url] => 
    [zjpjff] => LOE
    [zjfj] => 
    [tjqd] => 
    [nianfen] => 2022
    [guojia] => the European Society of Anaesthesiology and Intens
    [pdf] => 
    [tjyjyw] => 
    [lyyw] => Application of meticulous haemostasis should be considered a routine procedure.(Evidence: Level B,Recommendation: Class IIa)
    [laiyuan] => 应用细致的止血术应视为常规程序。(证据级别:B;推荐强度:IIa)
    [znzldj] => A
    [_inputtime] => 1734572562
    [_updatetime] => 1734572562
    [_nrjc] => 
    [_nrsh] => 
)
                
    						
    							推荐意见
									
										应用细致的止血术应视为常规程序。(证据级别:B;推荐强度:IIa)										
										   Application of meticulous haemostasis should be considered a routine procedure.(Evidence: Level B,Recommendation: Class IIa)										
									 
    							
    								证据评价方法:LOE
    								指南质量等级:A
    								年份:2022
    								国家:the European Society of Anaesthesiology and Intens
    							 
    							
								
    						 
                                                
                    Array
(
    [id] => 2175
    [catid] => 311
    [title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
    [thumb] => 
    [keywords] => 
    [description] => 
    [hits] => 
    [uid] => 3
    [author] => 甘肃中医院
    [status] => 9
    [url] => https://www.anes-guide.com/show/2175.html
    [link_id] => 0
    [tableid] => 0
    [inputip] => 14.105.95.116
    [inputtime] => 2024-12-19 09:42:42
    [updatetime] => 2024-12-19 09:42:42
    [displayorder] => 0
    [nrjc] => Array
        (
        )
    [nrsh] => Array
        (
        )
    [xzl] => 0
    [dzl] => 0
    [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
    [demo_url] => 
    [zjpjff] => LOE
    [zjfj] => 
    [tjqd] => 
    [nianfen] => 2022
    [guojia] => the European Society of Anaesthesiology and Intens
    [pdf] => 
    [tjyjyw] => 
    [lyyw] => A feedback/monitoring programme or clinical decision support system should be considered to be assessed before blood transfusion.(Evidence: Level B,Recommendation: Class IIa)
    [laiyuan] => 在输血前,应考虑采用反馈/监测程序或临床决策支持系统进行评估。(证据级别:B;推荐强度:IIa)
    [znzldj] => A
    [_inputtime] => 1734572562
    [_updatetime] => 1734572562
    [_nrjc] => 
    [_nrsh] => 
)
                
    						
    							推荐意见
									
										在输血前,应考虑采用反馈/监测程序或临床决策支持系统进行评估。(证据级别:B;推荐强度:IIa)										
										   A feedback/monitoring programme or clinical decision support system should be considered to be assessed before blood transfusion.(Evidence: Level B,Recommendation: Class IIa)										
									 
    							
    								证据评价方法:LOE
    								指南质量等级:A
    								年份:2022
    								国家:the European Society of Anaesthesiology and Intens
    							 
    							
								
    						 
                                                
                    Array
(
    [id] => 2176
    [catid] => 311
    [title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
    [thumb] => 
    [keywords] => 
    [description] => 
    [hits] => 
    [uid] => 3
    [author] => 甘肃中医院
    [status] => 9
    [url] => https://www.anes-guide.com/show/2176.html
    [link_id] => 0
    [tableid] => 0
    [inputip] => 14.105.95.116
    [inputtime] => 2024-12-19 09:42:42
    [updatetime] => 2024-12-19 09:42:42
    [displayorder] => 0
    [nrjc] => Array
        (
        )
    [nrsh] => Array
        (
        )
    [xzl] => 0
    [dzl] => 0
    [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
    [demo_url] => 
    [zjpjff] => LOE
    [zjfj] => 
    [tjqd] => 
    [nianfen] => 2022
    [guojia] => the European Society of Anaesthesiology and Intens
    [pdf] => 
    [tjyjyw] => 
    [lyyw] => Before allogenic blood transfusion, it should be considered to obtain an extensive consent about risks asssociated with transfusion.(Evidence: Level C,Recommendation: Class IIa)
    [laiyuan] => 异体输血前应对输血相关风险获得一致同意。(证据级别:C;推荐强度:IIa)
    [znzldj] => A
    [_inputtime] => 1734572562
    [_updatetime] => 1734572562
    [_nrjc] => 
    [_nrsh] => 
)
                
    						
    							推荐意见
									
										异体输血前应对输血相关风险获得一致同意。(证据级别:C;推荐强度:IIa)										
										   Before allogenic blood transfusion, it should be considered to obtain an extensive consent about risks asssociated with transfusion.(Evidence: Level C,Recommendation: Class IIa)										
									 
    							
    								证据评价方法:LOE
    								指南质量等级:A
    								年份:2022
    								国家:the European Society of Anaesthesiology and Intens
    							 
    							
								
    						 
                                                
                    Array
(
    [id] => 2177
    [catid] => 313
    [title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
    [thumb] => 
    [keywords] => 
    [description] => 
    [hits] => 
    [uid] => 3
    [author] => 甘肃中医院
    [status] => 9
    [url] => https://www.anes-guide.com/show/2177.html
    [link_id] => 0
    [tableid] => 0
    [inputip] => 14.105.95.116
    [inputtime] => 2024-12-19 09:42:42
    [updatetime] => 2024-12-19 09:42:42
    [displayorder] => 0
    [nrjc] => Array
        (
        )
    [nrsh] => Array
        (
        )
    [xzl] => 0
    [dzl] => 0
    [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
    [demo_url] => 
    [zjpjff] => LOE
    [zjfj] => 
    [tjqd] => 
    [nianfen] => 2022
    [guojia] => the European Society of Anaesthesiology and Intens
    [pdf] => 
    [tjyjyw] => 
    [lyyw] => If PCI is indicated before NCS, the use of new-generation DES is recommended over BMS and balloon angioplasty(Evidence: Level A ,Recommendation: Class I)
    [laiyuan] => CCS患者NCS之前如有PCI指征,建议使用新一代DES,而非BMS或球囊扩张。(证据级别:A;推荐强度:I)
    [znzldj] => A
    [_inputtime] => 1734572562
    [_updatetime] => 1734572562
    [_nrjc] => 
    [_nrsh] => 
)
                
    						
    							推荐意见
									
										CCS患者NCS之前如有PCI指征,建议使用新一代DES,而非BMS或球囊扩张。(证据级别:A;推荐强度:I)										
										   If PCI is indicated before NCS, the use of new-generation DES is recommended over BMS and balloon angioplasty(Evidence: Level A ,Recommendation: Class I)										
									 
    							
    								证据评价方法:LOE
    								指南质量等级:A
    								年份:2022
    								国家:the European Society of Anaesthesiology and Intens
    							 
    							
								
    						 
                                                
                    Array
(
    [id] => 2178
    [catid] => 313
    [title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
    [thumb] => 
    [keywords] => 
    [description] => 
    [hits] => 
    [uid] => 3
    [author] => 甘肃中医院
    [status] => 9
    [url] => https://www.anes-guide.com/show/2178.html
    [link_id] => 0
    [tableid] => 0
    [inputip] => 14.105.95.116
    [inputtime] => 2024-12-19 09:42:42
    [updatetime] => 2024-12-19 09:42:42
    [displayorder] => 0
    [nrjc] => Array
        (
        )
    [nrsh] => Array
        (
        )
    [xzl] => 0
    [dzl] => 0
    [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
    [demo_url] => 
    [zjpjff] => LOE
    [zjfj] => 
    [tjqd] => 
    [nianfen] => 2022
    [guojia] => the European Society of Anaesthesiology and Intens
    [pdf] => 
    [tjyjyw] => 
    [lyyw] => Pre-operative evaluation of patients with an indication for PCI by an expert team (surgeon and cardiologist) should be considered before elective NCS.(Evidence: Level C,Recommendation: Class IIa)
    [laiyuan] => CCS患者择期NCS前的PCI指证评估需包括外科医师和心内科医师。(证据级别:C;推荐强度:IIa)
    [znzldj] => A
    [_inputtime] => 1734572562
    [_updatetime] => 1734572562
    [_nrjc] => 
    [_nrsh] => 
)
                
    						
    							推荐意见
									
										CCS患者择期NCS前的PCI指证评估需包括外科医师和心内科医师。(证据级别:C;推荐强度:IIa)										
										   Pre-operative evaluation of patients with an indication for PCI by an expert team (surgeon and cardiologist) should be considered before elective NCS.(Evidence: Level C,Recommendation: Class IIa)										
									 
    							
    								证据评价方法:LOE
    								指南质量等级:A
    								年份:2022
    								国家:the European Society of Anaesthesiology and Intens
    							 
    							
								
    						 
                                                
                    Array
(
    [id] => 2179
    [catid] => 313
    [title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
    [thumb] => 
    [keywords] => 
    [description] => 
    [hits] => 
    [uid] => 3
    [author] => 甘肃中医院
    [status] => 9
    [url] => https://www.anes-guide.com/show/2179.html
    [link_id] => 0
    [tableid] => 0
    [inputip] => 14.105.95.116
    [inputtime] => 2024-12-19 09:42:42
    [updatetime] => 2024-12-19 09:42:42
    [displayorder] => 0
    [nrjc] => Array
        (
        )
    [nrsh] => Array
        (
        )
    [xzl] => 0
    [dzl] => 0
    [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
    [demo_url] => 
    [zjpjff] => LOE
    [zjfj] => 
    [tjqd] => 
    [nianfen] => 2022
    [guojia] => the European Society of Anaesthesiology and Intens
    [pdf] => 
    [tjyjyw] => 
    [lyyw] => Myocardial revascularization before high-risk elective NCS may be considered, depending on the amount of ischaemic myocardium, refractory symptoms, and findings at coronary angiography (as in the case of left main disease).(Evidence: Level B,Recommendation: Class IIb )
    [laiyuan] => 对于高风险择期CCS患者,可考虑NCS前行心肌血运重建,取决于缺血心肌数量、症状顽固程度、冠脉造影结果。(证据级别:B;推荐强度:IIb)
    [znzldj] => A
    [_inputtime] => 1734572562
    [_updatetime] => 1734572562
    [_nrjc] => 
    [_nrsh] => 
)
                
    						
    							推荐意见
									
										对于高风险择期CCS患者,可考虑NCS前行心肌血运重建,取决于缺血心肌数量、症状顽固程度、冠脉造影结果。(证据级别:B;推荐强度:IIb)										
										   Myocardial revascularization before high-risk elective NCS may be considered, depending on the amount of ischaemic myocardium, refractory symptoms, and findings at coronary angiography (as in the case of left main disease).(Evidence: Level B,Recommendation: Class IIb )										
									 
    							
    								证据评价方法:LOE
    								指南质量等级:A
    								年份:2022
    								国家:the European Society of Anaesthesiology and Intens
    							 
    							
								
    						 
                                                
                    Array
(
    [id] => 2180
    [catid] => 313
    [title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
    [thumb] => 
    [keywords] => 
    [description] => 
    [hits] => 
    [uid] => 3
    [author] => 甘肃中医院
    [status] => 9
    [url] => https://www.anes-guide.com/show/2180.html
    [link_id] => 0
    [tableid] => 0
    [inputip] => 14.105.95.116
    [inputtime] => 2024-12-19 09:42:42
    [updatetime] => 2024-12-19 09:42:42
    [displayorder] => 0
    [nrjc] => Array
        (
        )
    [nrsh] => Array
        (
        )
    [xzl] => 0
    [dzl] => 0
    [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
    [demo_url] => 
    [zjpjff] => LOE
    [zjfj] => 
    [tjqd] => 
    [nianfen] => 2022
    [guojia] => the European Society of Anaesthesiology and Intens
    [pdf] => 
    [tjyjyw] => 
    [lyyw] => Routine myocardial revascularization before lowand intermediate-risk NCS in patients with CCS is not recommended.(Evidence: Level B,Recommendation: Class III)
    [laiyuan] => CCS患者拟行低、中风险的NCS,不建议常规行术前心肌血运重建。(证据级别:B;推荐强度:III)
    [znzldj] => A
    [_inputtime] => 1734572562
    [_updatetime] => 1734572562
    [_nrjc] => 
    [_nrsh] => 
)
                
    						
    							推荐意见
									
										CCS患者拟行低、中风险的NCS,不建议常规行术前心肌血运重建。(证据级别:B;推荐强度:III)										
										   Routine myocardial revascularization before lowand intermediate-risk NCS in patients with CCS is not recommended.(Evidence: Level B,Recommendation: Class III)										
									 
    							
    								证据评价方法:LOE
    								指南质量等级:A
    								年份:2022
    								国家:the European Society of Anaesthesiology and Intens
    							 
    							
								
    						 
                                                
                    Array
(
    [id] => 2181
    [catid] => 313
    [title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
    [thumb] => 
    [keywords] => 
    [description] => 
    [hits] => 
    [uid] => 3
    [author] => 甘肃中医院
    [status] => 9
    [url] => https://www.anes-guide.com/show/2181.html
    [link_id] => 0
    [tableid] => 0
    [inputip] => 14.105.95.116
    [inputtime] => 2024-12-19 09:42:42
    [updatetime] => 2024-12-19 09:42:42
    [displayorder] => 0
    [nrjc] => Array
        (
        )
    [nrsh] => Array
        (
        )
    [xzl] => 0
    [dzl] => 0
    [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
    [demo_url] => 
    [zjpjff] => LOE
    [zjfj] => 
    [tjqd] => 
    [nianfen] => 2022
    [guojia] => the European Society of Anaesthesiology and Intens
    [pdf] => 
    [tjyjyw] => 
    [lyyw] => If NCS can safely be postponed (e.g. at least 3 months), it is recommended that patients with ACS being scheduled for NCS undergo diagnostic and therapeutic interventions as recommended for ACS patients in general.(Evidence: Level A ,Recommendation: Class I)
    [laiyuan] => 合并 ACS 的患者拟行NCS,建议推迟 NCS(如至少3个月),先按ACS 处理一般原则实施CAD 的诊断、治疗和干预。(证据级别:A;推荐强度:I)
    [znzldj] => A
    [_inputtime] => 1734572562
    [_updatetime] => 1734572562
    [_nrjc] => 
    [_nrsh] => 
)
                
    						
    							推荐意见
									
										合并 ACS 的患者拟行NCS,建议推迟 NCS(如至少3个月),先按ACS 处理一般原则实施CAD 的诊断、治疗和干预。(证据级别:A;推荐强度:I)										
										   If NCS can safely be postponed (e.g. at least 3 months), it is recommended that patients with ACS being scheduled for NCS undergo diagnostic and therapeutic interventions as recommended for ACS patients in general.(Evidence: Level A ,Recommendation: Class I)										
									 
    							
    								证据评价方法:LOE
    								指南质量等级:A
    								年份:2022
    								国家:the European Society of Anaesthesiology and Intens
    							 
    							
								
    						 
                                                
                    Array
(
    [id] => 2182
    [catid] => 313
    [title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
    [thumb] => 
    [keywords] => 
    [description] => 
    [hits] => 
    [uid] => 3
    [author] => 甘肃中医院
    [status] => 9
    [url] => https://www.anes-guide.com/show/2182.html
    [link_id] => 0
    [tableid] => 0
    [inputip] => 14.105.95.116
    [inputtime] => 2024-12-19 09:42:42
    [updatetime] => 2024-12-19 09:42:42
    [displayorder] => 0
    [nrjc] => Array
        (
        )
    [nrsh] => Array
        (
        )
    [xzl] => 0
    [dzl] => 0
    [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
    [demo_url] => 
    [zjpjff] => LOE
    [zjfj] => 
    [tjqd] => 
    [nianfen] => 2022
    [guojia] => the European Society of Anaesthesiology and Intens
    [pdf] => 
    [tjyjyw] => 
    [lyyw] => In the unlikely combination of a life-threatening clinical condition requiring urgent NCS, and NSTE-ACS with an indication for revascularization, the priorities for surgery on a case-by-case basis should be considered by the expert team.(Evidence: Level C,Recommendation: Class IIa)
    [laiyuan] => 一旦遇到合并有冠脉血运重建指证的 NSTE-ACS患者需行紧急NCS,应由专家团队基于具体情况 共同商议手术的优先顺序。(证据级别:C;推荐强度:IIa)
    [znzldj] => A
    [_inputtime] => 1734572562
    [_updatetime] => 1734572562
    [_nrjc] => 
    [_nrsh] => 
)
                
    						
    							推荐意见
									
										一旦遇到合并有冠脉血运重建指证的 NSTE-ACS患者需行紧急NCS,应由专家团队基于具体情况 共同商议手术的优先顺序。(证据级别:C;推荐强度:IIa)										
										   In the unlikely combination of a life-threatening clinical condition requiring urgent NCS, and NSTE-ACS with an indication for revascularization, the priorities for surgery on a case-by-case basis should be considered by the expert team.(Evidence: Level C,Recommendation: Class IIa)										
									 
    							
    								证据评价方法:LOE
    								指南质量等级:A
    								年份:2022
    								国家:the European Society of Anaesthesiology and Intens
    							 
    							
								
    						 
                                                
                    Array
(
    [id] => 2183
    [catid] => 313
    [title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
    [thumb] => 
    [keywords] => 
    [description] => 
    [hits] => 
    [uid] => 3
    [author] => 甘肃中医院
    [status] => 9
    [url] => https://www.anes-guide.com/show/2183.html
    [link_id] => 0
    [tableid] => 0
    [inputip] => 14.105.95.116
    [inputtime] => 2024-12-19 09:42:42
    [updatetime] => 2024-12-19 09:42:42
    [displayorder] => 0
    [nrjc] => Array
        (
        )
    [nrsh] => Array
        (
        )
    [xzl] => 0
    [dzl] => 0
    [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
    [demo_url] => 
    [zjpjff] => LOE
    [zjfj] => 
    [tjqd] => 
    [nianfen] => 2022
    [guojia] => the European Society of Anaesthesiology and Intens
    [pdf] => 
    [tjyjyw] => 
    [lyyw] => In patients with suspected or known HF scheduled for high-risk NCS, it is recommended to evaluate LV function with echocardiography and measurement of NT-proBNP/BNP levels, unless this has recently been performed.(Evidence: Level B,Recommendation: Class I)
    [laiyuan] => 疑似/确诊 HF 患者拟行高风险 NCS 前,建议 UCG 检查评估左室功能、并测定 NTproBNP/BNP水平(除非近期曾检查过)。(证据级别:B;推荐强度:I)
    [znzldj] => A
    [_inputtime] => 1734572562
    [_updatetime] => 1734572562
    [_nrjc] => 
    [_nrsh] => 
)
                
    						
    							推荐意见
									
										疑似/确诊 HF 患者拟行高风险 NCS 前,建议 UCG 检查评估左室功能、并测定 NTproBNP/BNP水平(除非近期曾检查过)。(证据级别:B;推荐强度:I)										
										   In patients with suspected or known HF scheduled for high-risk NCS, it is recommended to evaluate LV function with echocardiography and measurement of NT-proBNP/BNP levels, unless this has recently been performed.(Evidence: Level B,Recommendation: Class I)										
									 
    							
    								证据评价方法:LOE
    								指南质量等级:A
    								年份:2022
    								国家:the European Society of Anaesthesiology and Intens